Iodide uptake across the membranes of thyroid follicular cells and cancer cells occurs through an active transport process mediated by the sodium-iodide symporter (NIS). The rat and human NIS-coding genes were cloned and identified in 1996. Evaluation of NIS gene and protein expression is critical for the management of thyroid cancer, and several approaches to increase NIS levels have been tried. Identification of the NIS gene has provided a means of expanding its role in radionuclide therapy and molecular target-specific theragnosis (therapy and diagnosis using the same molecular target). In this article, we describe the relationship between NIS expression and the thyroid carcinoma treatment using I-131 and alternative therapeutic approaches.

Citations

Citations to this article as recorded by  

• A Pilot Nonrandomized Controlled Trial Examining the Use of Artificial Tears on the Radioactivity of Tears After Radioactive Iodine Treatment for Thyroid Cancer
  Irene T. Lee, Jared V. Grice, Xiangyu Ji, Qingxia Chen, Lindsay A. Bischoff, Aaron C. Jessop, Behin Barahimi, Francois Codere, Louise A. Mawn, Rachel K. Sobel
  Thyroid®.2024; 34(1): 82.     CrossRef
• Research progress of bone metastases: From disease recognition to clinical practice
  Wenbo Yang, Qing Pan, Fuhua Huang, Hongzhi Hu, Zengwu Shao
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Letter to the editor regarding “Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival”
  Maria José Veloza Vega, Manuela Gallo, Gonzalo Ucros, Patricia Bernal
  European Journal of Nuclear Medicine and Molecular Imaging.2022; 49(11): 3622.     CrossRef
• Factors Associated With Radioactive Iodine Therapy–Acquired Nasolacrimal Duct Obstruction
  Irene T. Lee, Wencong Chen, Qingxia Chen, Heather A. Cole, Lindsay A. Bischoff, Aaron C. Jessop, Rachel K. Sobel
  Endocrine Practice.2022; 28(12): 1210.     CrossRef
• RNA-Seq transcriptome analysis reveals Maackia amurensis leukoagglutinin has antitumor activity in human anaplastic thyroid cancer cells
  Suna Bektas, Engin Kaptan
  Molecular Biology Reports.2022; 49(10): 9257.     CrossRef
• Radio-Iodide Treatment: From Molecular Aspects to the Clinical View
  Antonio De la Vieja, Garcilaso Riesco-Eizaguirre
  Cancers.2021; 13(5): 995.     CrossRef
• Current Status and Future Perspective of the Treatment for Radioiodine Refractory Differentiated Thyroid Cancer
  Young Kee Shong
  International Journal of Thyroidology.2021; 14(2): 98.     CrossRef
• ¹⁸F-fluorodeoxyglucose positron emission tomography combined with computed tomography for the prediction of radioiodine therapy response in patients with metastatic differentiated thyroid cancer
  T. M. Geliashvili, A. V. Vazhenin, T. P. Berezovskaya, N. G. Afanasyeva, E. V. Vasilyeva, P. I. Garbuzov, V. V. Krylov
  Head and Neck Tumors (HNT).2020; 9(4): 10.     CrossRef
• Salivary side effects after radioiodine treatment for differentiated papillary thyroid carcinoma: Long‐term study
  Marc‐Kevin Le Roux, Nicolas Graillon, Laurent Guyot, David Taieb, Philippe Galli, Yves Godio‐Raboutet, Cyrille Chossegros, Jean‐Marc Foletti
  Head & Neck.2020; 42(11): 3133.     CrossRef
• β-radiating radionuclides in cancer treatment, novel insight into promising approach
  Samieh Asadian, Hamed Mirzaei, Bagher Aziz Kalantari, Mohamad Reza Davarpanah, Morteza Mohamadi, Anastasia Shpichka, Leila Nasehi, Hamidreza Aboulkheyr Es, Peter Timashev, Mustapha Najimi, Nematollah Gheibi, Moustapha Hassan, Massoud Vosough
  Pharmacological Research.2020; 160: 105070.     CrossRef
• Peptide Receptor Radionuclide Therapy in Patients With Differentiated Thyroid Cancer
  Dong Yun Lee, Yong-il Kim
  Clinical Nuclear Medicine.2020; 45(8): 604.     CrossRef
• FDG PET/CT for the early prediction of RAI therapy response in patients with metastatic differentiated thyroid carcinoma
  Seo Young Kang, Ji-In Bang, Keon Wook Kang, Ho-young Lee, June-Key Chung, Juri G. Gelovani
  PLOS ONE.2019; 14(6): e0218416.     CrossRef
• Role of iodide metabolism in physiology and cancer
  Antonio De la Vieja, Pilar Santisteban
  Endocrine-Related Cancer.2018; 25(4): R225.     CrossRef
• Star-Shaped Intense Uptake of 131I on Whole Body Scans Can Reflect Good Therapeutic Effects of Low-Dose Radioactive Iodine Treatment of 1.1 GBq
  Sung Hye Kong, Jung Ah Lim, Young Shin Song, Shinje Moon, Ye An Kim, Min Joo Kim, Sun Wook Cho, Jae Hoon Moon, Ka Hee Yi, Do Joon Park, Bo Youn Cho, Young Joo Park
  Endocrinology and Metabolism.2018; 33(2): 228.     CrossRef
• Sodium Iodide Symporter (NIS) in the Management of Patients with Thyroid Carcinoma
  June-Key Chung, Hyun Woo Kim, Haewon Youn, Gi Jeong Cheon
  Nuclear Medicine and Molecular Imaging.2018; 52(5): 325.     CrossRef
• LARP7 in papillary thyroid carcinoma induces NIS expression through suppression of the SHH signaling pathway
  Xiaomei Sui, Yana Sui, Yonghui Wang
  Molecular Medicine Reports.2018;[Epub]     CrossRef
• Human sodium iodide transporter gene-mediated imaging and therapy of mouse glioma, comparison between 188Re and 131I
  Rui Guo, Yun Xi, Min Zhang, Ying Miao, Miao Zhang, Biao Li
  Oncology Letters.2018;[Epub]     CrossRef
• Iodine-131 Therapy and Lacrimal Drainage System Toxicity: Nasal Localization Studies Using Whole Body Nuclear Scintigraphy and SPECT-CT
  Mohammad Javed Ali, Achyut Ram Vyakaranam, Jyotsna Eleshwarapu Rao, Giri Prasad, Palkonda Vijay Anand Reddy
  Ophthalmic Plastic & Reconstructive Surgery.2017; 33(1): 13.     CrossRef
• Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment
  Hossein Jadvar
  American Journal of Roentgenology.2017; 209(2): 277.     CrossRef
• Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer
  Arun Upadhyaya, Pingping Zhou, Zhaowei Meng, Peng Wang, Guizhi Zhang, Qiang Jia, Jian Tan, Xue Li, Tianpeng Hu, Na Liu, Sen Wang, Xiaoxia Liu, Huiying Wang, Chunmei Zhang, Fengxiao Zhao, Ziyu Yan, Xiaoran Wang, Xuemeng Zhang, Wan Zhang
  Nuclear Medicine Communications.2017; 38(11): 891.     CrossRef
• Effects of first radioiodine ablation on functions of salivary glands in patients with differentiated thyroid cancer
  Arun Upadhyaya, Zhaowei Meng, Peng Wang, Guizhi Zhang, Qiang Jia, Jian Tan, Xue Li, Tianpeng Hu, Na Liu, Pingping Zhou, Sen Wang, Xiaoxia Liu, Huiying Wang, Chunmei Zhang, Fengxiao Zhao, Ziyu Yan
  Medicine.2017; 96(25): e7164.     CrossRef
• Growth Kinetics of Macronodular Lung Metastases and Survival in Differentiated Thyroid Carcinoma
  Mijin Kim, Won Gu Kim, Suyeon Park, Hyemi Kwon, Min Ji Jeon, Sang Min Lee, Jeong Hyun Lee, Tae Yong Kim, Young Kee Shong, Won Bae Kim
  Thyroid.2017; 27(7): 915.     CrossRef
• Initial Size of Metastatic Lesions Is Best Prognostic Factor in Patients with Metastatic Differentiated Thyroid Carcinoma Confined to the Lung
  Mijin Kim, Won Gu Kim, Suyeon Park, Hyemi Kwon, Min Ji Jeon, Jong Jin Lee, Jin-Sook Ryu, Tae Yong Kim, Young Kee Shong, Won Bae Kim
  Thyroid.2017; 27(1): 49.     CrossRef
• Lack of Efficacy of Radioiodine Remnant Ablation for Papillary Thyroid Microcarcinoma: Verification Using Inverse Probability of Treatment Weighting
  Hyemi Kwon, Min Ji Jeon, Won Gu Kim, Suyeon Park, Mijin Kim, Tae Yong Kim, Minkyu Han, Dong Eun Song, Tae-Yon Sung, Jong Ho Yoon, Suck Joon Hong, Jin-Sook Ryu, Young Kee Shong, Won Bae Kim
  Annals of Surgical Oncology.2017; 24(9): 2596.     CrossRef
• Preparation and evaluation of 131I-quercetin as a novel radiotherapy agent against dedifferentiated thyroid cancer
  Qinghua Xie, Xia Li, Guanquan Wang, Xuan Hou, Yujun Wang, Hongbo Yu, Changfa Qu, Shunzhong Luo, Yali Cui, Chuanqin Xia, Ruibing Wang
  Journal of Radioanalytical and Nuclear Chemistry.2017; 311(3): 1697.     CrossRef
• Molecular radiotheragnostics in thyroid disease
  Nitasha Singh, Val Lewington
  Clinical Medicine.2017; 17(5): 453.     CrossRef
• Inhibition of BRD4 suppresses tumor growth and enhances iodine uptake in thyroid cancer
  Xuemei Gao, Xinchao Wu, Xiao Zhang, Wenjuan Hua, Yajing Zhang, Yusufu Maimaiti, Zairong Gao, Yongxue Zhang
  Biochemical and Biophysical Research Communications.2016; 469(3): 679.     CrossRef
• Hepatoprotective Effect of Dexmedetomidine Against Radioiodine Toxicity in Rats: Evaluation of Oxidative Status and Histopathologic Changes
  Kemal Kismet, Murat Sadic, Yusuf Murat Bag, Hasan Ikbal Atilgan, Gokhan Koca, Ali Kemal Onalan, Mehmet Senes, Seydi Ali Peker, Nihat Yumusak, Meliha Korkmaz
  International Surgery.2016; 101(3-4): 176.     CrossRef
• FoxP3 in papillary thyroid carcinoma induces NIS repression through activation of the TGF-β1/Smad signaling pathway
  Siyuan Ma, Qingzhu Wang, Xiaojun Ma, Lina Wu, Feng Guo, Hongfei Ji, Fei Liu, Yanyan Zhao, Guijun Qin
  Tumor Biology.2016; 37(1): 989.     CrossRef
• Iodine-131 Therapy and Nasolacrimal Duct Obstructions: What We Know and What We Need to Know
  Mohammad Javed Ali
  Ophthalmic Plastic & Reconstructive Surgery.2016; 32(4): 243.     CrossRef
• I-131 remnant ablation after thyroidectomy induced hepatotoxicity in a case of thyroid cancer
  Rong Lin, Omar Banafea, Jin Ye
  BMC Gastroenterology.2015;[Epub]     CrossRef
• Sub-Classification of Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma by Pathologic Criteria
  Min Ji Jeon, Won Gu Kim, Eun Kyung Jang, Yun Mi Choi, Dong Eun Song, Tae-Yon Sung, Jong Ho Yoon, Ki-Wook Chung, Suck Joon Hong, Jin-Sook Ryu, Ji Min Han, Tae Yong Kim, Young Kee Shong, Won Bae Kim, Konradin Metze
  PLOS ONE.2015; 10(7): e0133625.     CrossRef
• Targeted Radionuclide Therapy of Human Tumors
  Sergey Gudkov, Natalya Shilyagina, Vladimir Vodeneev, Andrei Zvyagin
  International Journal of Molecular Sciences.2015; 17(1): 33.     CrossRef
• Articles in 'Endocrinology and Metabolism' in 2014
  Won-Young Lee
  Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef